65
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Age differences in patterns of cannabis use among an online US sample of adults who consume cannabis frequently

, , , , , ORCID Icon, , & ORCID Icon show all
Pages 242-251 | Received 11 Apr 2023, Accepted 19 Jan 2024, Published online: 19 Apr 2024

References

  • Salas-Wright CP, Vaughn MG, Cummings-Vaughn LA, Holzer KJ, Nelson EJ, AbiNader M, Oh S. Trends and correlates of marijuana use among late middle-aged and older adults in the United States, 2002–2014. Drug Alcohol Depend. 2017;171:97–106. doi:10.1016/j.drugalcdep.2016.11.031.
  • Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R. National estimates of marijuana use and related indicators - national survey on drug use and health, United States, 2002–2014. MMWR Surveill Summ. 2016;65:1–28. doi:10.15585/mmwr.ss6511a1.
  • Han BH, Palamar JJ. Trends in cannabis use among older adults in the United States, 2015–2018. JAMA Intern Med. 2020;180:609–11. doi:10.1001/jamainternmed.2019.7517.
  • Maxwell CJ, Jesdale BM, Lapane KL. Recent Trends in Cannabis Use in Older Americans. Ann Intern Med. 2021;174:133–5. doi:10.7326/M20-0863.
  • Han BH, Sherman S, Mauro PM, Martins SS, Rotenberg J, Palamar JJ. Demographic trends among older cannabis users in the United States, 2006–13. Addiction. 2017;112:516–25. doi:10.1111/add.13670.
  • National Survey on Drug Use and Health. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration, Center For Behavioral Health Statistics and Quality; 2018. https://datafiles.samhsa.gov.
  • Connor JP, Stjepanovic D, Le Foll B, Hoch E, Budney AJ, Hall WD. Cannabis use and cannabis use disorder. Nat Rev Dis Primers. 2021;7:16. doi:10.1038/s41572-021-00247-4.
  • Leung J, Chan GCK, Hides L, Hall WD. What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addict Behav. 2020;109:106479. doi:10.1016/j.addbeh.2020.106479.
  • Minerbi A, Hauser W, Fitzcharles MA. Medical cannabis for older patients. Drugs Aging. 2019;36:39–51. doi:10.1007/s40266-018-0616-5.
  • Workman CD, Fietsam AC, Sosnoff J, Rudroff T. Increased likelihood of falling in older cannabis users vs. non-Users. Brain Sci. 2021;11:134. doi:10.3390/brainsci11020134.
  • Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc. 2003;9:679–89. doi:10.1017/S1355617703950016.
  • Schreiner AM, Dunn ME. Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis. Exp Clin Psychopharmacol. 2012;20:420–9. doi:10.1037/a0029117.
  • Meier MH, Caspi A, RK A, Hall W, Ambler A, Harrington H, Hogan SM, Houts R, Poulton R, Ramrakha S, et al. Long-term cannabis use and cognitive reserves and hippocampal volume in midlife. Am J Psychiatry. 2022;179:362–74.
  • Choi NG, Marti CN, DiNitto DM, Choi BY. Older adults’ marijuana use, injuries, and emergency department visits. Am J Drug Alcohol Abuse. 2018;44:215–23. doi:10.1080/00952990.2017.1318891.
  • Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology. 2018;43:195–212. doi:10.1038/npp.2017.198.
  • Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370:2219–27. doi:10.1056/NEJMra1402309.
  • Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Bloomfield MA, Curran HV, Baler R. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiarty. 2016;73:292–97. doi:10.1001/jamapsychiatry.2015.3278.
  • Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology. 2007;107:785–96. doi:10.1097/01.anes.0000286986.92475.b7.
  • Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, McDonald K, Ward A, Poulton R, Moffitt TE. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA. 2012;109:E2657–64. doi:10.1073/pnas.1206820109.
  • Freeman TP, Winstock AR. Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med. 2015;45:3181–9. doi:10.1017/S0033291715001178.
  • Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, Handley R, Luzi S, Russo M, Paparelli A, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry. 2009;195:488–91.
  • Petrilli K, Ofori S, Hines L, Taylor G, Adams S, Freeman TP. Association of cannabis potency with mental ill health and addiction: a systematic review. Lancet Psychiatry. 2022;9:736–50. doi:10.1016/S2215-0366(22)00161-4.
  • Russell C, Rueda S, Room R, Tyndall M, Fischer B. Routes of administration for cannabis use - basic prevalence and related health outcomes: a scoping review and synthesis. Int J Drug Policy. 2018;52:87–96. doi:10.1016/j.drugpo.2017.11.008.
  • Mauro PM, Carliner H, Brown QL, Hasin DS, Shmulewitz D, Rahim-Juwel R, Sarvet AL, Wall MM, Martins SS. Age differences in daily and nondaily cannabis use in the United States, 2002–2014. J Stud Alcohol Drugs. 2018;79:423–31. doi:10.15288/jsad.2018.79.423.
  • Santaella-Tenorio J, Levy NS, Segura LE, Mauro PM, Martins SS. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002–2016. Drug Alcohol Depend. 2019;205:107621. doi:10.1016/j.drugalcdep.2019.107621.
  • Earleywine M, Luba R, Slavin MN, Farmer S, Loflin M. Don’t wake and bake: morning use predicts cannabis problems. Addict Res Theory. 2016;24:426–30. doi:10.1080/16066359.2016.1177027.
  • ElSohly MA, Chandra S, Radwan M, Majumdar CG, Church JC. A comprehensive review of cannabis potency in the United States in the Last Decade. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6:603–06. doi:10.1016/j.bpsc.2020.12.016.
  • Spindle TR, Bonn-Miller MO, Vandrey R. Changing landscape of cannabis: novel products, formulations, and methods of administration. Curr Opin Psychol. 2019;30:98–102. doi:10.1016/j.copsyc.2019.04.002.
  • Bidwell LC, Martin-Willett R, Karoly HC. Advancing the science on cannabis concentrates and behavioural health. Drug Alcohol Rev. 2021;40:900–13. doi:10.1111/dar.13281.
  • Dowling GJ, Weiss SR, Condon TP. Drugs of abuse and the aging brain. Neuropsychopharmacology. 2008;33:209–18. doi:10.1038/sj.npp.1301412.
  • Lloyd SL, Striley CW. Marijuana use among adults 50 years or older in the 21st Century. Gerontol Geriatr Med. 2018;4:2333721418781668. doi:10.1177/2333721418781668.
  • Ueno LF, Mian MN, Altman BR, Giandelone E, Luce M, Earleywine M. Age-related differences in cannabis product use. J Psychoactive Drugs. 2021;53:312–8. doi:10.1080/02791072.2020.1870778.
  • Levy J Which cannabis products are popular among different age groups? 2020. https://www.vcstar.com/story/sponsor-story/hpc-port-hueneme/2020/09/22/which-cannabis-products-popular-among-different-age-groups/5825462002.
  • Kaufmann CN, Kim A, Miyoshi M, Han BH. Patterns of medical cannabis use among older adults from a cannabis dispensary in New York state. Cannabis Cannabinoid Res. 2022;7:224–30. doi:10.1089/can.2020.0064.
  • Colliver JD, Compton WM, Gfroerer JC, Condon T. Projecting drug use among aging baby boomers in 2020. Ann Epidemiol. 2006;16:257–65. doi:10.1016/j.annepidem.2005.08.003.
  • Kelfve S, Kivi M, Johansson B, Lindwall M. Going web or staying paper? The use of web-surveys among older people. BMC Med Res Methodol. 2020;20:252. doi:10.1186/s12874-020-01138-0.
  • Remillard ML, Mazor KM, Cutrona SL, Gurwitz JH, Tjia J. Systematic review of the use of online questionnaires of older adults. J Am Geriatr Soc. 2014;62:696–705. doi:10.1111/jgs.12747.
  • Tassiopoulos K, Roberts-Toler C, Fichtenbaum CJ, Koletar SL. Web-based data collection for older adults living with HIV in a clinical research setting: Pilot observational study. J Med Internet Res. 2020;22:e18588. doi:10.2196/18588.
  • Guillory J, Wiant KF, Farrelly M, Fiacco L, Alam I, Hoffman L, Crankshaw E, Delahanty J, Alexander TN. Recruiting hard-to-reach populations for survey research: using Facebook and Instagram Advertisements and In-person intercept in LGBT Bars and Nightclubs to recruit LGBT young adults. J Med Internet Res. 2018;20:e197. doi:10.2196/jmir.9461.
  • Kayrouz R, Dear BF, Karin E, Titov N. Facebook as an effective recruitment strategy for mental health research of hard to reach populations. Internet Interv. 2016;4:1–10. doi:10.1016/j.invent.2016.01.001.
  • Qualtrics. Qualtrics Survey Software. Provo, UT; 2022.
  • Kumar M, Jindal MK, Kumar M. A systematic survey on CAPTCHA recognition: types, creation and breaking techniques. Arch Comput Methods Eng. 2022;29:1107–36. doi:10.1007/s11831-021-09608-4.
  • Google. The official CAPTCHA site; 2013. http://www.captcha.net.
  • SAS Institute Inc. Base SAS® 9.4 procedures Guide: statistical procedures. 2nd ed. Cary, NC: SAS Institute Inc.; 2013. https://support.sas.com/documentation/cdl/en/procstat/66703/PDF/default/procstat.pdf.
  • Han BH, Palamar JJ. Marijuana use by middle-aged and older adults in the United States, 2015–2016. Drug Alcohol Depend. 2018;191:374–81. doi:10.1016/j.drugalcdep.2018.07.006.
  • Blazer DG, Wu LT. The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health. Am J Geriatr Psychiatry. 2009;17:237–45. doi:10.1097/JGP.0b013e318190b8ef.
  • Haug NA, Padula CB, Sottile JE, Vandrey R, Heinz AJ, Bonn-Miller MO. Cannabis use patterns and motives: a comparison of younger, middle-aged, and older medical cannabis dispensary patients. Addict Behav. 2017;72:14–20. doi:10.1016/j.addbeh.2017.03.006.
  • Jeffers AM, Glantz S, Byers A, Keyhani S. Sociodemographic characteristics associated with and prevalence and frequency of cannabis use among adults in the US. JAMA Netw Open. 2021;4:e2136571. doi:10.1001/jamanetworkopen.2021.36571.
  • Lee CM, Neighbors C, Woods BA. Marijuana motives: young adults’ reasons for using marijuana. Addict Behav. 2007;32:1384–94. doi:10.1016/j.addbeh.2006.09.010.
  • Yang KH, Kaufmann CN, Nafsu R, Lifset ET, Nguyen K, Sexton M, Han BH, Kim A, Moore AA. Cannabis: an emerging treatment for common symptoms in older adults. J Am Geriatr Soc. 2021;69:91–97. doi:10.1111/jgs.16833.
  • Subbaraman MS, Kerr WC. Cannabis use frequency, route of administration, and co-use with alcohol among older adults in Washington state. J Cannabis Res. 2021;3:17. doi:10.1186/s42238-021-00071-3.
  • Ribeiro LI, Ind PW. Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review. NPJ Prim Care Respir Med. 2016;26:16071. doi:10.1038/npjpcrm.2016.71.
  • Hancox RJ, Poulton R, Ely M, Welch D, Taylor DR, McLachlan CR, Greene JM, Moffitt TE, Caspi A, Sears MR, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35:42–7.
  • Wei TT, Chandy M, Nishiga M, Zhang A, Kumar KK, Thomas D, Manhas A, Rhee S, Justesen JM, Chen IY, et al. Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation. Cell. 2022;185:1676–93 e23. doi:10.1016/j.cell.2022.04.005.
  • Goodman S, Hammond D. Noticing of cannabis health warning labels in Canada and the US. Health Promot Chronic Dis Prev Can. 2021;41:201–10. doi:10.24095/hpcdp.41.7/8.01.
  • Kruger DJ, Korach NJ, Kruger JS. Requirements for cannabis product labeling by U.S. State. Cannabis Cannabinoid Res. 2022;7:156–60. doi:10.1089/can.2020.0079.
  • Centers for Disease Control and Prevention. Outbreak of lung Injury associated with the use of E-Cigarette, or vaping, products. 2019. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html.
  • Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiarty. 2015;72:1235–42.
  • Tourangeau R, Yan T. Sensitive questions in surveys. Psychol Bull. 2007;133:859–83. doi:10.1037/0033-2909.133.5.859.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.